IGS PHARMA
The computed 12-month bankruptcy probability of IGS PHARMA is 3.1% (moderate). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 6 yrs |
| Locations | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro | 09-06-2026 | 2026-00146549 |
| 31-12-2022 | micro | 19-10-2023 | 2023-00490582 |
| 31-12-2021 | volledig | 18-10-2022 | 2022-20465026 |
| 31-12-2020 | volledig | 30-08-2021 | 2021-62000154 |
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 18-12-2019 |
| Status | Active |
| Postal code | 1060 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21562A0227/00E005 | Brussels | 146 m² | 1 · 146 m² | 23.3 m · 7 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | IGS PHARMA |